Recall
FDAHealthNovember 4, 2024

Boulla LLC — PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com

⚠️ Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 4, 2024

Nationwide within the United States

What's affected?

Product
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Lot code
230811

Additional details

Lot #: 230811, Exp: 08/11/2025

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: Unknown.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.